Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP212932.RAL4E56rRaGF4RZN4EdmzSKZGS6etWp5rXw-lQTnAL0Gk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP212932.RAL4E56rRaGF4RZN4EdmzSKZGS6etWp5rXw-lQTnAL0Gk130_assertion type Assertion NP212932.RAL4E56rRaGF4RZN4EdmzSKZGS6etWp5rXw-lQTnAL0Gk130_head.
- NP212932.RAL4E56rRaGF4RZN4EdmzSKZGS6etWp5rXw-lQTnAL0Gk130_assertion description "[These results show the lack of clinical effectiveness of imatinib in UM, which was originally anticipated based on the high levels of KIT and SCF expression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP212932.RAL4E56rRaGF4RZN4EdmzSKZGS6etWp5rXw-lQTnAL0Gk130_provenance.
- NP212932.RAL4E56rRaGF4RZN4EdmzSKZGS6etWp5rXw-lQTnAL0Gk130_assertion evidence source_evidence_literature NP212932.RAL4E56rRaGF4RZN4EdmzSKZGS6etWp5rXw-lQTnAL0Gk130_provenance.
- NP212932.RAL4E56rRaGF4RZN4EdmzSKZGS6etWp5rXw-lQTnAL0Gk130_assertion SIO_000772 19118061 NP212932.RAL4E56rRaGF4RZN4EdmzSKZGS6etWp5rXw-lQTnAL0Gk130_provenance.
- NP212932.RAL4E56rRaGF4RZN4EdmzSKZGS6etWp5rXw-lQTnAL0Gk130_assertion wasDerivedFrom befree-20140225 NP212932.RAL4E56rRaGF4RZN4EdmzSKZGS6etWp5rXw-lQTnAL0Gk130_provenance.
- NP212932.RAL4E56rRaGF4RZN4EdmzSKZGS6etWp5rXw-lQTnAL0Gk130_assertion wasGeneratedBy ECO_0000203 NP212932.RAL4E56rRaGF4RZN4EdmzSKZGS6etWp5rXw-lQTnAL0Gk130_provenance.